Find out about our latest news and events.

News

Thursday, 16 May 2024

The discovery of a new critical enzyme could help engineer climate resilient crops capable of sucking far more carbon dioxide from the atmosphere in a much more efficient way.

Read the article
Wednesday, 16 Aug 2023

Professor Alexander Maier wants us to change our mind about parasites.

Read the article
Sacha Pulsford
Monday, 09 May 2022

Meet the PhD researcher exploring how bacterial proteins could hold the key to reducing our reliance on fossil fuels.

Read the article
Friday, 06 May 2022

Researchers have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global fight against the disease.

Read the article
Tuesday, 28 Sep 2021

A low-cost, non-toxic cancer treatment has been developed by researchers at The Australian National University (ANU). The treatment uses dead bacteria to help kick-start the immune system and shrink cancer.

Read the article
Thursday, 04 Mar 2021

Researchers from The Australian National University (ANU) have exposed a fatal flaw in the deadly parasite that causes malaria - one of the world's biggest killers.

Read the article

Events

27 Aug 2020 | 2pm

PhD exit seminar by Elizabeth Whitty of the Callaghan Group. Research School of Biology - Division of Biomedical Science and Biochemisitry.

Read the article
27 Aug 2020 | 1pm

PhD exit seminar by Elizabeth Whitty of the Callaghan Group. Research School of Biology - Division of Biomedical Science and Biochemisitry.

Read the article
5 Mar 2020 | 1 - 2:30pm

PhD exit seminar by Sanduni Hapuarachchi from the van Dooren Group at the Research School of Biology, whose work highlights the important roles transporters play in parasites and open avenues to further explore this important class of proteins.

Read the article
2 Mar 2020 | 12 - 1pm

The emergence and spread of Plasmodium falciparum parasites that are resistant to front-line antimalarial artemisinin-combination therapies (ACT) threatens to erase the considerable gains against the disease of the last decade. We developed a new large-scale phenotypic screening pipeline and used it to carry out the fi

Read the article
28 Feb 2020 | 1 - 2:30pm

Audrey Odom John, Chief of the Division of Infectious Diseases at Children’s Hospital of Philadelphia. A physician-scientist, Dr. John’s NIH-funded research has focused on Plasmodium falciparum malaria parasites, with a particular interest in targeting parasite metabolism to identify novel targets for drug development

Read the article
27 Feb 2020 | 1 - 2:30pm

Special BSB and CBA Seminar exploring evolution by Yoshinori Tomoyasu Department of Biology, Miami University

Read the article